Study Suggests Ozempic's Active Ingredient, Semaglutide, May Slow Aging Process

AI-generated NewsSnap summary based on source reporting.
Published: 2026-09-12
Category: science
Source: ScienceDaily

An NIH-funded study found that semaglutide, the active ingredient in drugs like Ozempic, extended the lifespan of older, healthy mice and improved memory, muscle function, and blood sugar control. Published findings indicate that its anti-aging effects surpassed those of calorie restriction, suggesting GLP-1 drugs may influence fundamental biological pathways linked to longevity.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai